AAAAAA
Results:
1-11
|
Results: 11
Authors:
ROZENBERG S
KROLL M
VANDROMME J
PAESMANS M
LEFEVER A
HAM H
Citation: S. Rozenberg et al., FACTORS INFLUENCING THE PRESCRIPTION OF OSTEOPOROSIS THERAPY AMONG GYNECOLOGISTS, Journal of bone and mineral research, 12, 1997, pp. 526-526
Authors:
ROZENBERG S
KROLL M
VANDROMME J
PAESMANS M
LEFEVER A
HAM H
Citation: S. Rozenberg et al., FACTORS INFLUENCING THE PRESCRIPTION OF HORMONE REPLACEMENT THERAPY, Obstetrics and gynecology, 90(3), 1997, pp. 387-391
Authors:
LUM LG
TREISMAN J
TAYLOR RF
LEFEVER A
Citation: Lg. Lum et al., PHASE-I II TRIAL OF ACTIVATED T-CELLS (ATC), IL-2 AND GM-CSF AFTER PBSC TRANSPLANT FOR STAGE-IIIB OR STAGE-IV BREAST-CANCER/, Blood, 90(10), 1997, pp. 4462-4462
Authors:
GARLIE NK
LUM LG
LEFEVER A
Citation: Nk. Garlie et al., INDUCTION OF HIGH-LEVELS OF IFN-GAMMA PRODUCTION BY T-CELLS COACTIVATED WITH ANTI-CD3 ANTI-CD28 (COACTS) IN THE PRESENCE OF IL-12/, Blood, 90(10), 1997, pp. 2026-2026
Authors:
ROZENBERG S
KROLL M
VANDROMME J
HAM H
LEFEVER A
RIERA C
PAESMANS M
Citation: S. Rozenberg et al., PHYSICIANS ATTITUDE TOWARDS HORMONE REPLACEMENT THERAPY PRESCRIPTION FOR POSTMENOPAUSAL OSTEOPOROSIS PREVENTION, Journal of bone and mineral research, 11, 1996, pp. 639-639
Authors:
ROSENFELD CS
BOLWELL B
LEFEVER A
TAYLOR R
LIST A
FAY J
COLLINS R
ANDREWS F
PALLANSCH P
SCHUSTER MW
RESTA D
LEVITT D
NEMUNAITIS J
Citation: Cs. Rosenfeld et al., COMPARISON OF 4 CYTOKINE REGIMENS FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS - IL-3 ALONE AND COMBINED WITH GM-CSF OR G-CSF, Bone marrow transplantation, 17(2), 1996, pp. 179-183
Authors:
JIN NR
LEFEVER A
LEVINE BL
JUNE CH
LUM LG
Citation: Nr. Jin et al., COSTIMULATION OF T-CELLS WITH IMMOBILIZED ANTI-CD3 ANTI-CD28 (OKT3/9.3) INDUCES AND MAINTAINS NON-MHC RESTRICTED CYTOTOXICITY/, Blood, 88(10), 1996, pp. 2892-2892
Authors:
FUNAHASHI A
HARLAND RW
LEFEVER A
Citation: A. Funahashi et al., ASSOCIATION OF INCREASED PROSTAGLANDIN E(2) CONTENT IN BRONCHOALVEOLAR LAVAGE FLUID AND INTRATHORACIC MALIGNANCY, Chest, 106(1), 1994, pp. 166-172
Authors:
BOLWELL B
ROSENFELD C
LEFEVER A
LIST A
ANDREWS F
SCHUSTER M
LEVITT D
RESTA D
GEORGE M
NEMUNAITIS J
COLLINS R
Citation: B. Bolwell et al., A PHASE-II TRIAL OF G-CSF WITH OR WITHOUT SDZ ILE-964 (IL-3) FOR THE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) FOR AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000106-10000106
Authors:
NEMUNAITIS J
ROSENFELD C
BOLWELL B
LEFEVER A
TAYLOR R
FAY J
COLLINS R
LIST A
SCHUSTER M
RESTA D
PALLANSCH P
LEVITT D
Citation: J. Nemunaitis et al., PHASE-II RANDOMIZED TRIAL COMPARING SDZ-ILE-964 (RHIL-3) TO SEQUENTIAL AND COMBINATION ADMINISTRATION OF RHIL-3 AND LEUKINE(R) OR NEUPOGEN(R) IN THE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS FOR AUTOLOGOUS TRANSPLANT (PBSCT) IN PATIENTS WITH LYMPHOID MALIGNANCY OR BREAST-CANCER, Blood, 82(10), 1993, pp. 10000365-10000365
Authors:
HARLAND R
FUNAHASHI A
LEFEVER A
Citation: R. Harland et al., IDENTIFICATION OF CELLS IN BRONCHOALVEOLAR LAVAGE FLUID RESPONSIBLE FOR ELEVATED PROSTAGLANDIN-E2 IN PATIENTS WITH LUNG-CANCER, The American review of respiratory disease, 147(4), 1993, pp. 331-331
Risultati:
1-11
|